Extract from acquisition announcement today: "T
Post# of 807
"The Purchase Price of $120 million includes very stringent Net Revenue Warranties and appropriate performance penalties as agreed upon by the Sellers of BioCann. BioCann has warranted Net Attributable Revenues of not less than $12 million for the period April 1, 2019 to March 31, 2020 . These are explained in very specific detail in the referenced Filing. All of the Equity Instruments being issued in settlement of this acquisition are restricted from any sale and/or conversion for a period of not less than 18 (Eighteen) months. The shares of restricted Common Stock were issued at a price of $0.03 ( Three cents ) per share."
GNCC Capital Inc. (GNCP) Stock Research Links
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.